F. Marhuenda

EGFR Expression Is Unreliable to Decide for Cetuximab Treatment in Patients with Metastatic Colorectal Cancer: Results from “ERBITUX-OUEST”

J. Douillard, N. Padilla, J. Raoul, 2016 .

Long survival of patients with metastatic clear cell renal cell carcinoma. Results of real life study of 344 patients

F. Joly, J. Malhaire, E. Voog, 2020, International journal of cancer.

Differential Dependence on Beclin 1 for the Regulation of Pro-Survival Autophagy by Bcl-2 and Bcl-xL in HCT116 Colorectal Cancer Cells

M. Priault, L. Oliver, F. Vallette, 2010, PloS one.

Efficacy and safety of panitumumab in a cohort of patients with metastatic colorectal cancer in France: PANI OUEST, a post-EMA-approval descriptive study with a geriatric oncology focus.

J. Douillard, J. Metges, Z. Alavi, 2020, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.

Hypoxia and the malignant glioma microenvironment: regulation and implications for therapy.

M. Campone, L. Oliver, C. Olivier, 2009, Current molecular pharmacology.

Hypoxia and the Malignant Glioma Microenvironment: Regulation and Implications for Therapy

M. Campone, L. Oliver, F. Vallette, 2009 .

Clinical validation of a prognostic tool in a population of outpatients treated for incurable cancer undergoing anticancer therapy: PRONOPALL study

E. Blot, P. Ingrand, J. Douillard, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Evaluation in usual practice of the bevacizumab-FOLFIRI combination for the first-line treatment of patients with unresectable metastatic colorectal cancer treated in 2006: focus on resected patients and oncogeriatrics

J. Douillard, P. Langlet, E. Jobard, 2014, Oncologie.